N4 Pharma posts optimistic Nuvec research update

N4 Pharma, a specialist pharmaceutical company focused on developing the Nuvec delivery system for cancer treatments and vaccines, issued an optimistic update on its ongoing in-vitro siRNA research efforts on Thursday.

Related Keywords

Nigel Theobald , , Polo Like Kinase , Pharma , Posts , Optimistic , Nuvec , Research , Update , Category All , Category Market Report , Category Company News , Category News And Announcements , Category Small Caps News , Category Aim Bulletin , Category Tecnologia , Category Market Pulse , Category Sectorial Health Technology ,